AllianceBernstein’s DarioHealth DRIO Stock Holding History

AllianceBernstein’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,905	Closed	-$494K	–	3282
2021 Q4	$494K	Buy	+1,905	New	+$579K	﹤0.01%	2744

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein's DRIO Position: Q1 2022 in Review

AllianceBernstein sold out of DarioHealth (DRIO) in Q1 2022, closing a stake of 1,905 shares — an estimated $494K sold.

AllianceBernstein first reported a position in DRIO in Q4 2021 and held it in 1 quarter. The position peaked at $494K in Q4 2021. 63 funds tracked by Wall St. Rank hold DRIO as of Q1 2022.

AllianceBernstein reported no remaining DarioHealth position as of Q1 2022 after selling out during the quarter.
AllianceBernstein sold 1,905 DarioHealth shares in Q1 2022, an estimated $494K.
AllianceBernstein first reported a position in DarioHealth in Q4 2021 and held it in 1 quarter.
AllianceBernstein's DarioHealth position peaked at $494K in Q4 2021.
63 funds tracked by Wall St. Rank held DarioHealth as of Q1 2022.

Based on AllianceBernstein's 13F filing for Q1 2022, filed 13 May 2022.